9/28/2020 1:05:29 AM
Genentech Reports New 2-year Data From Part 1 Of Pivotal FIREFISH Study Of Evrysdi
9/19/2020 10:27:38 AM
Roche Says Phase III IMpassion131 Study Did Not Meet Primary Endpoint Of Progression-free Survival
9/18/2020 9:38:10 AM
Roche Gets Positive CHMP Opinion For Tecentriq In Combination With Avastin
9/18/2020 1:12:45 AM
Roche Launches Elecsys Anti-SARS-CoV-2 S Antibody Test
9/18/2020 1:04:21 AM
Genentech Says Phase III EMPACTA Study Meets Primary Endpoint
9/17/2020 1:08:00 AM
Roche To Present New And Updated Data From Broad Cancer Portfolio At ESMO Virtual Congress 2020
9/16/2020 1:03:33 AM
Roche Gets FDA Approval For Expanded Use Of CINtec® PLUS Cytology
9/11/2020 1:05:14 AM
Genentech Announces New Data Of Ocrevus For People With Multiple Sclerosis
9/10/2020 1:03:28 AM
Roche Says ENSPRYNG Lowered Relapse Severity In Double-blind Periods Of SAkura Phase III Studies
9/9/2020 1:04:49 AM
Roche Initiates Novel Clinical Trials For OCREVUS
9/9/2020 1:04:47 AM
Genentech Expands Multiple Sclerosis Portfolio With Investigational BTK Inhibitor Fenebrutinib